Carregant...

Heart Rate Changes Following the Administration of Sugammadex to Infants and Children With Comorbid Cardiac, Cardiovascular, and Congenital Heart Diseases

BACKGROUND: Sugammadex is a novel, rapidly-acting pharmacologic agent to reverse steroidal neuromuscular blocking agents with demonstrated advantages over acetylcholinesterase inhibitors. However, anecdotal reports have noted rare instances of bradycardia and even cardiac arrest. The current study e...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Cardiol Res
Autors principals: Arends, Jordan, Hubbard, Richard, Shafy, Shabana Z., Hakim, Mohammed, Kim, Stephani S., Tumin, Dmitry, Tobias, Joseph D.
Format: Artigo
Idioma:Inglês
Publicat: Elmer Press 2020
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7430884/
https://ncbi.nlm.nih.gov/pubmed/32849961
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.14740/cr1045
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!